Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.148
+0.008 (0.67%)
After-hours: Jun 26, 2026, 7:23 PM EDT
Pliant Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Pliant Therapeutics stock have an average target of 2.67, with a low estimate of 2.00 and a high estimate of 3.00. The average target predicts an increase of 134.21% from the current stock price of 1.14.
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Pliant Therapeutics stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 6 | 6 | 5 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 8 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 | Hold | Maintains | $3 | +163.16% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $3 | Buy | Maintains | $3 | +163.16% | May 12, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $2 | Hold | Maintains | $2 | +75.44% | May 12, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.00M
EPS This Year
-1.42
from -2.40
EPS Next Year
-0.95
from -1.42
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 15.0M | |
| Avg | n/a | 3.0M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 733.3% |
| Avg | - | 108.3% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.29 | 0.49 | |
| Avg | -1.42 | -0.95 | |
| Low | -1.56 | -1.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.